Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05992324 · ClinicalTrials.gov registry record · NA
A Validation Study to Evaluate the Performance of Caption Health Lung Guidance and Interpretation
A NA study of Shortness of Breath, sponsored by Caption Health.
- Recruiting
- Registry status
- NA
- Development phase
- 220
- Enrollment target
- 4
- Study locations
NCT05992324 is a NA study of Shortness of Breath that is actively recruiting participants, run by Caption Health. The registered enrollment target is 220 participants, above the 64-participant average among 6 other Shortness of Breath trials with a reported enrollment target (244% higher). The trial reports 4 study locations across 3 states.
The verdict
NCT05992324, a NA study of Shortness of Breath, is actively recruiting participants, sponsored by Caption Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 220 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to assess the efficacy of Caption LungAI.
Conditions Studied
Interventions
- DEVICE Caption LungAI
Study Locations (4)
Illinois
- Northwestern University - Chicago
- Rush University Medical Center - Chicago
Connecticut
- Yale New Haven Hospital - New Haven
North Carolina
- The Moses H. Cone Memorial Hospital - Greensboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2023-07-17 |
| Est. Completion | 2025-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05992324
The ClinicalTrials.gov registry entry for NCT05992324 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 64-participant average among 6 other Shortness of Breath trials with a reported enrollment target (244% higher). The listed sponsor is Caption Health, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Shortness of Breath appearing as the primary indexed condition, and to 1 intervention - of which Caption LungAI is the first listed.
NCT05992324 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Illinois, Connecticut, North Carolina.
Frequently Asked Questions
What is clinical trial NCT05992324 about?
NCT05992324 is a clinical study titled "A Validation Study to Evaluate the Performance of Caption Health Lung Guidance and Interpretation". The purpose of this study is to assess the efficacy of Caption LungAI.
What is the current status of trial NCT05992324?
This trial is currently recruiting. It is a NA study. The enrollment target is 220 participants. The study started on 2023-07-17. Estimated completion is 2025-03-01.
What conditions does trial NCT05992324 study?
This clinical trial studies the following conditions: Shortness of Breath.
What interventions are being tested in trial NCT05992324?
The interventions under investigation include: Caption LungAI (DEVICE).
Who is sponsoring clinical trial NCT05992324?
This trial is sponsored by Caption Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05992324 being conducted?
This trial has 4 study locations across Connecticut, Illinois, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Shortness of Breath
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Determinants of Cardiorespiratory Fitness and Effects of HIIT in Patients With ANOCA Obstructive Coronary Artery Disease(ANOCA)
RECRUITING · NA
-
Virtual Teach-to-Goal Education vs. Brief Education for Children
COMPLETED · NA
-
Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department
COMPLETED · NA
-
Cardiopulmonary Exercise Testing and Oscillometry for the Evaluation of Dyspnea
RECRUITING
-
Work of Breathing Assessment in Triage Scale
ACTIVE NOT RECRUITING
-
Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.